Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects
Phase 2
Terminated
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- AlloCure Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT01602328
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of California, San Diego, San Diego, California, United States
🇺🇸Stanford Hospital and Clinics, Stanford, California, United States
Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery
Phase 1
Completed
- Conditions
- Kidney Tubular Necrosis, Acute
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- AlloCure Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00733876
- Locations
- 🇺🇸
Intermountain Medical Center, Murray, Utah, United States
🇺🇸St Mark's Hospital, Salt Lake City, Utah, United States
News
No news found